Neuropeptide Y reverses corticotropin-releasing hormone- and psychological stress-caused shortening of sodium pentobarbital-induced sleep in rats

Brain Research

Volumn 725, Issue 2, 1996, Pages 272-275

  Yamada, Konagi ^a   Shibasaki, Tamotsu ^b   Tsumori, Chiaki ^a   Imaki, Toshihiro ^a   Hotta, Mari ^a   Wakabayashi, Ichiji ^b   Demura, Hiroshi ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^b NIPPON MEDICAL SCHOOL   (Japan)

Author keywords

Arousal; Corticotropin releasing hormone; Locomotor activity; Neuropeptide Y; Psychological stress; Sedative action; Sodium pentobarbital

Indexed keywords

CORTICOTROPIN RELEASING FACTOR; NALOXONE; NEUROPEPTIDE Y; OPIATE ANTAGONIST; PENTOBARBITAL;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; ELECTRIC SHOCK; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; INTRAPERITONEAL DRUG ADMINISTRATION; LOCOMOTION; MALE; MENTAL STRESS; NONHUMAN; PRIORITY JOURNAL; RAT; SEDATION; SLEEP INDUCTION;

EID: 0030182402     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/0006-8993(96)00405-2     Document Type: Article

References (30)

1. [1] Bird, S.J. and Kuhar, M.J., Iontophoretic application of opiates to the locus coeruleus, Brain Res., 122 (1977) 523-533.
2. [2] Butler, P.D., Weiss, J.M., Stout, J.C. and Nemeroff, C.B., Corticotropin-releasing factor produces fear-enhancing and behavioral activating effects following infusion into the locus coeruleus, J. Neurosci., 10 (1990) 176-183.
3. [3] Clark, J.J., Karla, P.S., Crowle, W.R. and Karla, S.P., Neuropeptide Y and human pancreatic polypeptide stimulate feeding behavior in rats, Endocrinology, 115 (1984) 427-429.
4. [4] Dunn, A.J. and Berridge, C.W., Physiological and behavioral responses to corticotropin-releasing factor administration: is CRF a mediator of anxiety or stress responses?, Brain Res. Rev., 15 (1990) 71-100.
5. [5] Harvey, S.C., Hypnotics and sedatives. In A.G. Gilman, L.S. Goodman, T.W. Rall and F. Murad (Eds.), The Pharmacological Basis of Therapeutics, 7th ed., Macmillan Publishing Company, New York, 1985, pp. 339-371.
6. [6] Heilig, M., Wahlestedt, C. and Widerlov, E., Neuropeptide Y (NPY)-induced suppression of activity in the rat: evidence for NPY receptor heterogeneity and for interaction with α-adrenoceptors, Eur. J. Pharmacol., 157 (1988) 205-213.
7. [7] Heilig, M., Soederpalm, B., Engel, A.J. and Wirderloev, E., Centrally administered neuropeptide Y (NPY) produces anxiolytic-like effects in animal anxiety models, Psychopharmacology, 98 (1989) 524-529.
8. [8] Imaki, T., Shibasaki, T., Masuda, A., Shizume, K. and Ling, N., The antagonistic effect of corticotropin-releasing factor on pentobarbital in rats, Brain Res., 383 (1986) 323-326.
9. [9] Korf, J., Bunny, B.S. and Aghajanian, G.K., Noradrenergic neurons: morphine inhibition of spontaneous activity, Eur. J. Pharmacol., 25 (1974) 165-169.
10. [10] Krahn, D.D., Gasnell, B.A., Grace, M.,and Levine, A.S., CRF antagonist partially reverses CRF-and stress induced effects on feeding. Brain Res. Bull., 17 (1986) 285-289.
11. [11] Levine, A.S. and Morley, J.E., Neuropeptide Y: a potent inducer of consummatory behavior in rats, Peptides, 5 (1984) 1025-1029.
12. [12] Morley, J.E. and Levine, A.S., Corticotrophin releasing factor, grooming and ingestive behavior, Life Sci., 31 (1982) 1459-1464.
13. [13] Pert. C.B. Kuhar, M.J. and Snyder, S.H., Autoradiographic localization of the opiate receptor in rat brain, Life Sci., 16 (1975) 1849-1853.
14. [14] Schick, R.R., Schusdziarra, V., Nussbaumer, N. and Classen, M., Neuropeptide Y and food intake in fasted rats: effect of naloxone and site of action, Brain Res., 552 (1991) 232-239.
15. [15] Shibasaki, T., Kim, Y.S., Yamauchi, N., Masuda, A., Imaki, T., Hotta, M., Demura, H., Wakabayashi, I. and Shizume, K., Antagonistic effect of somatostatin on corticotropin-releasing factor-induced anorexia in the rat, Life Sci., 42 (1988) 329-334.
16. [16] Shibasaki, T., Yamauchi, N., Hotta, M., Imaki, T., Oda, T., Ling, N. and Demura, H., Brain corticotropin-releasing hormone increases arousal in stress. Brain Res., 554 (1991) 352-354.
17. [17] Shibasaki, T., Oda, T., Imaki, T., Ling, N. and Demura, H., Injection of anti-neuropeptide Y γ-globulin into the hypothalamic paraventricular nucleus decreases food intake in rats, Brain Res., 601 (1993) 313-316.
18. [18] Shibasaki, T., Imaki, T., Hotta, M., Ling, N. and Demura, H., Psychological stress increases arousal through brain corticotropin-releasing hormone without significant increase in adrenocorticotropin and catecholamine secretion, Brain Res., 618 (1993) 71-75.
19. [19] Shibasaki, T., Imaki, Hotta, M., Ling, N. and Demura, H., Restraint changes pentobarbital-induced sleeping time in rats: evidence that arousal is modulated by brain corticotropin-releasing hormone and opioid in stress, Regul. Pept., 51 (1994) 141-149.
20. [20] Stanley, B.C. and Leiwitz, S.F., Neuropeptide Y: stimulation of feeding and drinking by injection into the paraventricular nucleus, Life Sci., 35 (1984) 2635-2642.
21. [21] Tazi, A., Danzer, R. LeMoal, M., Rivier, J., Vale, W.W. and Koob, G.F., Corticotropin-releasing factor antagonist blocks stress-induced fighting in rats, Regul. Pept., 18 (1987) 37-42
22. [22] Thompson, R.C., Monsour, A., Akil, H. and Watson, S.J., Cloning and pharmachological characterization of a rat mu opioid recepter, Neuron, 11 (1993) 903-913.
23. [23] Valentino, R.J., Foote, S.L. and Astones, G., Corticotropin-releasing factor activates noradrenergic neurons of the locus coeruleus, Brain Res., 270 (1983) 363-367.
24. [24] Valentino, R.J. and Wehby, R.G., Corticotropin-releasing factor: evidence for a neurotransmitter role in the locus coeruleus during hemodynamic stress, Neuroendocrinology, 48 (1988) 674-677.
25. [25] Wahlestedt, C., Skagerberg, G., Ekman, R., Heilig, M., Sundler, F. and Hakanson, R., Neuropeptide Y (NPY) in the area of the hypothalamic paraventricular nucleus activates the pituitary-adrenocortical axis in the rat, Brain Res. 417 (1987) 33-38.
26. [26] Wahlestedt, C., Pich, E.M., Koob, G.F., Yee, F. and Heilig, M., Modulation of anxiety and neuropeptide Y-Y1 receptors by antisense oligodeoxynucleotides, Science, 259 (1993) 528-531.
27. [27] Walter, M.J., Scherrer, J.F., Flood, J.F. and Morley, J.E., Effects of localized injections of neuropeptide Y antibody on motor activity and other behaviors, Peptides, 15 (1994) 607-613.
28. [28] Widdowson, P.S., Quantitative receptor autoradiography demonstrates a differential distribution of neuropeptide-Y Y1 and Y2 receptor subtypes in human and rat brain, Brain Res., 631 (1993) 27-38.
29. [29] Widerloev, E., Lindstroem, L.H., Wahlestedt, C. and Ekman, R., Neuropeptide Y and peptide YY as possible cerebrospinal fluid markers for major depression and schizophrenia, respectively, J. Psychiatr. Res., 22 (1988) 69-79.
30. [30] Young, III, W.S., Bird, S.J. and Kuhar, M.J., Iontophoresis of methionine-enkephalin in the locus coeruleus area, Brain Res., 129 (1977) 366-370.